ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$1.49
-0.08 (-5.10%)
As of Mar 31, 10:16 PM ET ·
Financial Highlights (FY 2026)
Revenue
85.90M
Net Income
-1,997,253,719
Gross Margin
41.8%
Profit Margin
-2,325.2%
Rev Growth
D/E Ratio
0.97
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 41.8% 47.7% 47.7% 47.7%
Operating Margin -2,238.0% 21.1% 17.6% 19.8%
Profit Margin -2,325.2% 12.8% 15.1% 11.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 85.90M 335.8K 347.3K 304.4K
Gross Profit 35.90M 160.1K 165.5K 145.1K
Operating Income -1,922,311,385 70.8K 61.3K 60.4K
Net Income -1,997,253,719 43.0K 52.4K 35.7K
Gross Margin 41.8% 47.7% 47.7% 47.7%
Operating Margin -2,238.0% 21.1% 17.6% 19.8%
Profit Margin -2,325.2% 12.8% 15.1% 11.7%
Rev Growth +0.6% +12.6% -7.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 568.5K 556.4K 513.3K 557.3K
Total Equity 585.7K 947.6K 993.8K 1.02M
D/E Ratio 0.97 0.59 0.52 0.55
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,849,127,079 73.2K 78.8K 66.7K
Free Cash Flow 45.7K 64.8K 36.1K